ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FAB Fusion Antibodies Plc

3.75
-0.05 (-1.32%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.32% 3.75 3.70 3.80 3.80 3.75 3.80 474,407 11:29:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.38 3.58M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.80p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.875p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.58 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.38.

Fusion Antibodies Share Discussion Threads

Showing 326 to 346 of 4100 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
18/9/2020
11:20
Im actually godsmacked this has such huge potential its unreal
roger148
18/9/2020
11:19
Tidy

It's better than the testing shares.

I missed the point they could provide antigens for tests until they mentioned it.

My interest is the coat antibodies to neutralise covid which the CEO goes on about in interviews.

The CEO is not good at PR. Doc did try to arise the profile but few paid attention.

BUT if you look at the underlying business it;'s growing anyway and looking very good, making Covid imo a free bet.

But for months no one had paid attention, they have completely missed it.

Just 26 mill shares most of which are held by large holders. I estimate 7 mill or so shares for PIs to fight over.

Some will think Bio big fund raises for trails, NO FAB are a service provider who took the wise decision to develop covid options 'for sale' themselves.

It looks like it was good idea, as they have done this over 200 times before on viruses, the Covid plan was always likely to be a success.

superg1
18/9/2020
11:15
good post -
tomboyb
18/9/2020
11:10
Roger

Nah they raised £3 mill specifically for Covid research.

Typically they are a service provider on demand from major pharmas who pay them to engineer antibodies.

In the case of Covid they decided to raise money produce the antibodies test it then offer it to pharmas.

They are not a big spend company they do not fund drugs trials.

It's a very interesting company in the antibody sector who could in theory end up with a finger in neutralising meds for Covid.

As explained in posts the whole problem with Covid and viruses, is the body takes up to 2 weeks to develop antibodies.

This way patients get a shot in the arm of covid killing antibodies that the body accepts.

That's the plan, big pharma will do the testing and trials when they sign up.

Such sign ups seem inevitable after that news. Most big names already use Fusion as a service provider

superg1
18/9/2020
11:08
Good luck to holders one that eluded me I sold out at a pound hoping to get back in before news. Made mistake here but hope it goes on to continue to rocket for you all
fund1
18/9/2020
11:07
Guess I shouldn’t have sold these for a quid. Back now at 169p lol
Should always back my hometown firms

volsung
18/9/2020
11:07
Only 37m cap. Looking at x10 imo compare to AVCT NCYT SNG caps now from this level
tidy 2
18/9/2020
11:05
2 quid plus by the look of it -
tomboyb
18/9/2020
11:01
I actually agree for once Cnt knock mcap is very low and news is out as the pandemic is coming back
roger148
18/9/2020
10:57
This is impressive news for a now 37m cap company with plenty of dosh in the bank and supplying all the big pharmas.
tidy 2
18/9/2020
10:57
Good read https://spongeshare.com/research/fusion-antibodies-research-note-part-2/?amp&__twitter_impression=true
maverick247
18/9/2020
10:56
Ok seen it Hold my hands up
roger148
18/9/2020
10:55
Until you check out their balance sheet.
tidy 2
18/9/2020
10:48
Would say a placing is on route
roger148
18/9/2020
10:45
1/10th the cap of other covid stocks. They are not supplying 8 of the top 10 pharmas unlike FAB now is.
tidy 2
18/9/2020
10:36
Getting a bit hot under the collar -
tomboyb
18/9/2020
10:33
Compare cap here to the recent star covid stocks AVCT NCYT SNG All over £300m cap from FABs low level cap of £32m
tidy 2
18/9/2020
10:27
hTTps://www.fusionantibodies.com/collaborations/
tidy 2
18/9/2020
10:27
Acuere

Was that the general antibody type news re progress.

I though Fab would see interest due to that but some sold.

It forces the point that the market is pretty much oblivious to FAB and its tech. No dob that will change in the coming days and weeks as the usual crew catch on.

Some had flirted around it like Doc but the 9.30 news will have caught many out.

The underlying business looks interesting before Covid featured.

In theory a long way to go for the share price in the coming years on the underlying business but Covid will accelerate that.

In theory big pharmas will sign up as they will want a finger in all the pies.

superg1
18/9/2020
10:26
Surely strong buys to come?
allstars001
18/9/2020
10:25
acuere18 Sep '20 - 10:14 - 174 of 175
0 1 0
No time to check but is this related to the Eli Lilly announcement this week?

no idea -

if it is then it could be big big -

will take a look -

tomboyb
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older